SELECT-SWITCH Study Design Intro: 12-week, randomized, double blind, head-to-head (H2H), Phase 3b/4 study that evaluated the efficacy and safety of RINVOQ (upadacitinib) + MTX versus HUMIRA (adalimumab) + MTX in 491 adult patients with moderate to severe RA who demonstrated prior failure to one non-adalimumab TNF inhibitor
That speedo will keep all your delicates well-protected
Tobacco prices vary widely depending on brand, type, and region, so its difficult to say a universal per-spliff cost
I'm gonna head up." You rise from your seat in the awkward quiet
Undergraduate students, who had currently been smoking, had quit and never smoked, were selected through purposive sampling and invited to participate in the study